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Abstract
The human respiratory tract is constantly exposed to a wide variety of viruses, microbes and inorganic particulates from
environmental air, water and food. Physical characteristics of inhaled particles and airway mucosal immunity determine
which viruses and microbes will persist in the airways. Here we present the first metagenomic study of DNA viral
communities in the airways of diseased and non-diseased individuals. We obtained sequences from sputum DNA viral
communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease. Overall, diversity of viruses in the
airways was low, with an average richness of 175 distinct viral genotypes. The majority of viral diversity was uncharacterized.
CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage
communities, which may reflect organisms in inhaled air. CF eukaryotic viral communities were dominated by a few viruses,
including human herpesviruses and retroviruses. Functional metagenomics showed that all Non-CF viromes were similar,
and that CF viromes were enriched in aromatic amino acid metabolism. The CF metagenomes occupied two different
metabolic states, probably reflecting different disease states. There was one outlying CF virome which was characterized by
an over-representation of Guanosine-59-triphosphate,39-diphosphate pyrophosphatase, an enzyme involved in the bacterial
stringent response. Unique environments like the CF airway can drive functional adaptations, leading to shifts in metabolic
profiles. These results have important clinical implications for CF, indicating that therapeutic measures may be more
effective if used to change the respiratory environment, as opposed to shifting the taxonomic composition of resident
microbiota.
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Introduction
Each day the human respiratory tract comes into contact with
billions of airborne particles, including viruses, microbes and
allergens [1]. Particle size and the local airway host immune
response determine which inhaled viruses and particles will adhere
to epithelial surfaces and persist in the airways [1,2]. The lungs
and lower respiratory tract have generally been considered sterile
in the absence of respiratory disease although very little is known
about the microbiota of the upper and lower airways of non-
diseased individuals. Microbes and viruses, including phage, have
been implicated in chronic pulmonary diseases, such as chronic
obstructive pulmonary disease (COPD), asthma, and cystic fibrosis
(CF) [3–8]. However, most of this work has been performed using
standard microbial cultures and PCR-based studies, which provide
an incomplete picture of the airway microbiota and little
opportunity for viral discovery compared to metagenomic
techniques.
Metagenomics is a powerful tool for viral and microbial
community characterization since nucleic acids are isolated
directly from environmental samples and sequenced, requiring
no culturing, cloning, or a priori knowledge of what viruses may be
present. Viruses are the most numerous and diverse biological
entities on Earth, and metagenomics has been used extensively to
describe viral communities in marine ecosystems [9–12]. The first
metagenomic studies of the human microbiome were of viruses in
blood, feces, and the lungs, and went far to describe previously
unexplored viral communities [13–17]. Recent metagenomic
studies of the human microbiome have largely focused on
microbial populations, predominantly in the gut and the surface
of the skin [18–21].
Cystic fibrosis is an autosomal recessive genetic disease caused
by a mutation in the cystic fibrosis transmembrane conductance
regulator protein (CFTR), a gated ion channel [22,23]. CF affects
paranasal sinuses as well as the lower respiratory, hepatobiliary,
pancreatic and lower gastro-intestinal tracts [23]. The current
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7370median age of survival for individuals with CF is approximately 38
years. Over 80% of CF mortalities are attributable to respiratory
failure from chronic bacterial infections of the lungs, most
commonly caused by Pseudomonas aeruginosa, Staphylococcus aureus,
and Burkholderia cepacia [4,24]. Individuals with CF have impaired
mucociliary clearance (MCC) which results in airway mucus
plugging [2][25][2]. This creates hypoxic microenvironments,
forcing invasive microbial species to adapt [2]. This unique airway
environment is believed to increase viral replication and
susceptibility to viral infections in individuals with CF [8,22].
Expectorated sputum provides a sample of airway secretions from
the proximal airways. Sputum also contains material from the
entire respiratory tract including airway mucus, cellular debris,
DNA, and degraded proteins as well as microbes, their associated
phage, and eukaryotic viruses [26,27].
Here we report the first metagenomic study of airway DNA
viral communities using sputum samples from both cystic fibrosis
and Non-cystic fibrosis (Non-CF) individuals, including the spouse
of an individual with CF and an individual with mild asthma. Viral
communities from Non-CF volunteers were characterized and
compared to viromes of individuals with cystic fibrosis to
determine if there is a core respiratory tract virome in non-
diseased individuals. Metabolic profiles inferred from metage-
nomic sequences were distinctly different between Non-CF and
CF viromes. Our results indicate that regardless of the presence or
absence of shared taxa, a core set of metabolic functions defines
the non-diseased and diseased respiratory tract DNA viromes.
Results and Discussion
Phage taxonomy reflects airway pathology
In all metagenomes, the majority of sequences (.90%) were
unknown when compared to the non-redundant database using
BLASTn (Table S1), which is comparable to the percentage of
unknown sequences in other environmental viromes [9,12,28]. CF
viromes had more tBLASTx similarities to phage genomes overall
than Non-CF viromes, and were similar to a wider range of phage
(Figure 1, Table S2). The tBLASTx analysis identified a core set of
Figure 1. Mapping of best tBLASTx hits to the phage proteomic tree by percentage for Non-CF (A) and CF (B) viromes. The phage
genome with the highest percentage of hits (normalized to the length of the genome) is labeled for each virome.
doi:10.1371/journal.pone.0007370.g001
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metagenomes (Table S3). An additional 12 genomes had
significant similarities to viromes from all CF individuals but none
of the Non-CF individuals. This suggests a core set of phage
characteristic of the human respiratory tract, and an additional
core group in CF individuals. A few phage genomes appeared to
dominated the Non-CF2, Non-CF3, and Non-CF5 viromes when
tBLASTx similarities to phage genomes were plotted against the
Phage Proteomic Tree (Figure 1). Over 90% of tBLASTx hits to
phage in Non-CF2 were to Streptococcus phage Cp-1, and 80% of
tBLASTx similaritites in Non-CF3 were attributable to two phage,
Haemophilus influenza phage HP-1 and Brucella melitensis 16 M BrucI
prophage. The large relative abundance of these phage may reflect
their prevalence in inhaled air, since environmental air has been
shown to contain diverse bacterial communities [29].
The phage profiles of Non-CF1Asthma and Non-CF4Spouse
were more similar to those of CF individuals than to other Non-CF
individuals. This likeness was confirmed by PCA (Figure 2). Non-
CF1Asthma and Non-CF4Spouse had values for the first and
second principal components which were nearly identical to those
of the CF metagenomes. The other Non-CF metagenomes had
more random distribution of phage genotypes and did not appear
to cluster on the PCA graph. More specifically, Non-CF2,
NonCF3, and Non-CF5 all had positive values for the first
principal component (0.40, 0.42, and 0.27 respectively) while all
other metagenomes had negative values. This was driven by a
large positive loading of the first principal component by the
Streptococcus phage Cp-1, which segregated Non-CF2, and negative
loadings on the set of phage genomes shared by Non-CF1Asthma,
Non-CF4Spouse and the CF metagenomes. Additionally, the
second principal component was positively loaded by the Brucella
melitensis 16 M phi Bruc1 prophage genome which was nearly
absent in Non-CF2, giving a negative value of the second principal
component for Non-CF2.
These results indicate that the sputum phage community in
Non-CF individuals appears to represent a random, transient
sampling of the exterior environment. In CF individuals, phage
communities are driven by airway pathology, and correspond to a
shared internal respiratory environment. The phage community in
the Non-CF4Spouse virome reflects a continuous sampling of CF-
associated phage via a shared external environment. Common
phage taxonomy in CF individuals and Non-CF1Asthma occurs
because of shared respiratory pathology (i.e., similar internal
environments). Both CF and asthma are conditions marked by
impaired mucociliary clearance (MCC) [2,25,30]. MCC is slowed
in asthma, leading to increased retention of microbes and hence
their phage [30]. In CF, mucus is extremely viscous and stagnant,
forming obstructive plugs, and creating hypoxic microenviron-
ments that serve as scaffolds for bacterial biofilm formation [2,25].
Therefore, in both asthma and CF, phage communities are
derived from microbes which persist in the airways for longer
periods of time than in healthy individuals.
Inferred host ranges for respiratory tract phage
The putative microbial host range of respiratory tract phage
reflected a few dominant but distinct phage in Non-CF2, Non-
CF3, and Non-CF5 (Figure 3).Host ranges of Non-CF1Asthma
and Non-CF4Spouse were highly similar to those of the CF phage
communities, but were under-represented in Streptococcus and
Staphylococcus phage. The higher abundance of Staphylococcus phage
in CF is consistent with the increased induction of Staphylococcus
prophage by antibiotics in CF individuals, as shown by previous
studies [31]. P. aeruginosa was cultured from the sputum of all CF
participants, yet Pseudomonas phage were not abundant in the
metagenomes. Pseudomonas phage may be of novel types not closely
related to those in the database, making them undetectable by
tBLASTx. Even if known phage are present, infections of
Pseudomonas in CF may be unsuccessful, since phage may not be
able to penetrate the biofilm to access susceptible microbial hosts
[32]. Alternatively, P. aeruginosa may not be as abundant in the CF
airway as indicated by culturing, an idea supported by 16S rDNA
and Terminal Restriction Fragment Polymorphism (T-RFLP)
analysis of bacteria in CF sputum and bronchoalveolar lavage fluid
[33–35]. T-RFLP uses fluorescently labeled 59 PCR primers
coupled with restriction digests to allow for rapid profiling of
unknown microbial communities, providing a less biased picture of
microbial diversity than culture-based studies [35].
Diversity of respiratory tract viruses
There were approximately 175 unique species of DNA viruses
in respiratory tract viral communities (Table 1). There were no
significant differences in the estimated number of species between
CF and Non-CF viromes. Diversity estimates were based on
sequence assemblies and PHACCs, so all metagenomic sequences
were used, not just those with BLAST similarities to viral
databases [36]. The estimated number of DNA viral species has
been reported to be as low as 1440 in hot springs, and as high as
129,000 in the open ocean [9,37]. In comparison with other
environmental viromes, the respiratory tract viromes had low
species richness. Similarly, Rogers et al. [34] found low diversity of
Bacteria in CF sputum using T-RFLP analysis. Low species
richness probably results from physical and biological barriers to
microbial and viral persistence, including both MCC as well as
innate and adaptive immunity [2,38]. Richness may be further
depressed in CF individuals because of antibiotic therapies and the
metabolic adaptations required for microbial and viral survival in
the unique microenvironment of the CF airway [26,27].
Cross-BLASTn analysis showed that CF viromes shared more
sequences with each other than Non-CF viromes. Sequences from
each metagenome were compared pairwise to all other metagen-
omes using BLASTn to identify shared sequences as explained in
Figure 2. Principal components analysis (PCA) of respiratory
tract viromes based on phage taxonomic composition. Non-CF
metagenomes are shown in blue and CF metagenomes are shown in
red. Inputs to PCA were normalized percentages of best tBLASTx hits to
completely sequenced phage genomes. Non-CF1Asthma and Non-
CF4Spouse cluster with the CF metagenomes.
doi:10.1371/journal.pone.0007370.g002
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not found in any Non-CF metagneomes. Sequential BLAST
analysis identified 31,413 sequences common to all CF viromes,
and 12,824 of these did not appear in any of the Non-CF viromes.
Non-CF viromes shared 11,995 sequences, and 330 could not be
found in any CF virome. Both the larger group of shared and
unique sequences in CF metagenomes suggests that CF viral
communities are more similar than Non-CF communities.
Taxonomy of eukaryotic viruses
Eukaryotic DNA viral communities in CF individuals were
dominated by a few viral genomes which were highly variable in
their abundances. Non-CF individuals shared numerous eukary-
otic viruses with more even abundances, suggestive of a core
virome (Figure 4A). All CF metagenomes had similarities (.1%) to
Reticuloendotheliosis virus (Figure S1) and other retro-transcrib-
ing viruses (Figure 4B). We confirmed bioinformatically that
similarities to retroviruses were not actually similarities to the
human genome, therefore, we assume that retroviruses must have
been present in the metagenomes as DNA intermediates.
indicating that retroviruses may establish persistent infections in
the airways, and could be useful therapeutic vectors for CF as
previously suggested [40]. CF viromes also shared several human
herpesviruses (HHV) including Epstein-Barr virus (HHV-4),
HHV-6B, and HHV-8P. Infection with Epstein-Barr virus in
adolescent CF patients has been linked to exacerbations and poor
clinical outcomes, and has also been observed in adults [41].
CF2 and CF4 had many similarities to Geminiviruses and
Nanoviruses, single-stranded DNA viruses of plants (Figure 4B).
However, these similarities were concentrated at one location in
the genome, the coding sequence for the replication initiator (Rep)
protein. Specifically, they were localized to the WalkerA and
WalkerB motifs of Rep which correspond to an ATP-binding
domain in the translated protein [42]. ATP-binding motifs are
common to Rep proteins from a variety of viruses, including
Geminiviruses, Nanoviruses, Circoviruses, Parvoviruses, and
phage [42]. Therefore, tBLASTx similarities to specific Rep
motifs indicate the presence of a virus, but not specifically a
Gemini- or Nanovirus.
Non-CF viromes had similarities to fewer unique viral genomes,
that is, there were fewer genomes with tBLASTx hits only in one
virome (Table S4). Non-CF3 had significant similarities to a
Geminivirus, but all hits were to the WalkerA and Walker B motifs
of the Rep protein. Human papillomavirus Type 34 comprised
Figure 3. Putative host range for phage communities in respiratory tract viromes. Host range was inferred from normalized best tBLASTx
hits to phage genomes. Host ranges for CF viromes and for Non-CF1Asthma and Non-CF4Spouse were not statistically significantly different as
determined by XIPE and were combined.
doi:10.1371/journal.pone.0007370.g003
Table 1. Diversity estimates for human respiratory tract DNA
viromes.
Sample Species Richness Evenness Shannon Index
NonCF1Asthma 164 0.89 4.52
NonCF2 156 0.95 4.81
NonCF3 113 0.94 4.45
NonCF4Spouse 187 0.94 4.92
NonCF5 594 0.86 5.46
NonCF Mean 243 0.92 4.83
CF1 69 0.85 3.85
CF2 154 0.86 4.34
CF3 104 0.8 4.32
CF4 121 0.92 4.42
CF5 75 0.84 3.91
CF Mean 105 0.85 4.17
Overall Mean 174 0.89 4.5
Repeated sets of 10000 random sequences were retrieved from each
metagenome and assembled to obtain contig spectra. Diversity modeling
based on contig spectra was performed with PHACCs, using a logarithmic
model and an average genome size of 50 kb.
doi:10.1371/journal.pone.0007370.t001
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Non-CF2 also had many similarities to Human papillomavirus
type 71. Human papillomaviruses have been been detected
previously in the respiratory tract and are commonly found in
tumors in the lungs and the oropharynx [43–45].
The majority of viral species found in Non-CF viromes were from
a core set of 20 viral genomes, which were shared by allmetagenomes
(Table S5; Figure S2). These included a mammalian adenovirus
(Bovine adenovirus A), eight mammalian herpesviruses, and three
poxviruses.Adenovirusesandherpesviruseshavebeendetectedinthe
airways of both CF and Non-CF individuals, and tBLASTx
similarities to non-human viruses represent related undiscovered
human variants [8]. Several other viruses, such as algal and insect
viruses, were shared among all metagenomes, but similarities to these
viruses were largely concentrated in one area of the genome. Since
metagenomics allows direct sequencing of environmental DNA,
metagenomic techniques often isolate novel viruses and microbes.
The hallmark of a novel viral genotype is a large concentration of
sequences in one discrete region of a previously sequenced genome.
Therefore, these results suggest the presence of a novel virus common
to all individuals which cannot be identified using database
similarities, analogous to viruses detected in human blood [15].
Figure 4. Distribution of normalized best tBLASTx hits to DNA and Retro-transcribing eukaryotic viruses in Non-CF(A) and CF(B)
individuals. Reticuloendotheliosis virus is indicated by the red rectangle in (B).
doi:10.1371/journal.pone.0007370.g004
Respiratory Viromes
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Non-CF individuals were confirmed by PCA (Figure 5). Non-CF
viromes all had nearly identical values for the first and second
principal components, resulting in a tight cluster on the graph.
This was largely driven by the general absence of ssDNA and
Retro-transcribing viruses from Non-CF viromes (Figure 4A).
Principal components for CF viromes were more variable,
reflecting the tendency for CF viromes to have a small number
(between one and four) of highly abundant viral species.
Specifically, the outlying behavior of CF2 was driven by a high
positive loading of the second principal component by the
Geminivirus Sugarcane streak Egypt virus. CF4 did not cluster
with other metagenomes due to a high negative loading of the first
principal component by Reticuloendotheliosis virus.
In Non-CF individuals, eukaryotic viral communities likely
represent transient infections rapidly cleared by immune cells or
viral particles being removed from the airway via MCC. In CF
individuals, communities probably correspond to more persistent
infections. Viral replication is increased in the CF airway and
synergism between persistent bacteria and incipient eukaryotic
viruses pre-disposes CF individuals to acquiring viral infections
[8]. This is in contrast to asthma, where the sequelae of viral
infections are often severe in the lower respiratory tract, yet
individuals are no more likely to acquire such infections [3]. It is
difficult to distinguish clinical symptoms of viral infections from the
typical respiratory distress associated with CF, so it is possible that
CF individuals in this study could have had extant viral infections
[8].
Metabolic profiles of respiratory tract viruses
Non-CF individuals shared a common viral metabolic profile
which was distinctly different from that of CF individuals
(Figure 6). Functional annotations were assigned to metagenomic
sequences by tBLASTx comparison to the non-redundant SEED
database at the highest subsystem level, which consists of 25
classifications (Figure 7A). The percentage of known sequences
(i.e., sequences with significant similarity to the database) was
much higher than reported in the literature for other viral
metagenomes (Figure S3) [28].
Metabolic functions encoded by viruses are determined by the
environment, and functional genes carried by phage largely mirror
those of their hosts [28]. The CF airway has distinct regions
characterized by hypoxia and low pH, and airway secretions are
enriched in amino acids, DNA, phospholipids and other cellular
debris [4,26]. The specific adaptations required for survival in this
environment are reflected by the metabolic profiles of CF viromes.
Non-CF1Asthma and Non-CF4Spouse shared phage taxonomy
with CF viromes, but did not share metabolic profiles because they
have a Non-CF airway environment. These results are similar to
findings in the human gut, where microbiomes were determined to
share a set of core metabolic genes even when different microbial
taxa were present, and aberrant physiological states (i.e., obesity)
lead to definitive changes in the metabolic consortium [21]. As
indicated by CF5, there may be more than one disease state which
defines metabolism in CF, reflecting differences in pathology,
disease development and/or treatment regimes.
All of the CF metagenomes (including CF5) were over-
represented in functions related to the metabolism of aromatic
compounds (Figure 7A). At the second hierarchical subsystem
level, CF1-4 were over-represented in anaerobic degradation of
aromatics, while CF5 had more genes related to peripheral
catabolism pathways, most of which were aerobic (Figure 7B).
Non-CF metagenomes were enriched for metabolism of central
intermediates via aerobic mechanisms. CF sputum is derived from
hypoxic microenvironments which require persistent microbes to
acquire anaerobic adaptations [26]. Aromatic amino acids have
been implicated both as preferred carbon sources and also
regulators of quinolone signaling and biofilm formation for
Pseudomonas aeruginosa in CF sputum [26,27].
The presence of anaerobic aromatic catabolism genes in phage
may represent lateral gene transfer with well-adapted hosts [46].
Alternatively, phage may be degrading aromatics in order to
reduce biofilm formation and the exopolysaccharide layer,
allowing access to susceptible Bacterial hosts.
CF5 was dramatically over-represented in phosphorous metab-
olism and virulence pathways (Figure 7A). Over 75% of tBLASTx
similarities to the phosphorous metabolism subsystem were to the
gene encoding Guanosine-59-triphosphate,39-diphosphate pyro-
phosphatase. This enzyme catalyzes the removal of a phosphate
group from guanosine pentaphosphate (pppGpp) to generate
Figure 5. Principal components analysis based on best
tBLASTx hits to 3074 eukaryotic viruses. Non-CF viromes are
shown in blue and CF viromes are shown in red.
doi:10.1371/journal.pone.0007370.g005
Figure 6. Non-metric multidimensional (NM-MDS) scaling of
top-level SEED metabolic subsystems. All Non-CF metagenomes
are shown in blue. CF1-5 are shown in red. The inputs to NM-MDS were
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are part of the canonical bacterial stringent response which is
enacted to slow growth rates during nutrient stress [48]. They have
also been linked to bacterial virulence, antibiotic resistance,
biofilm formation, quorum sensing, and phage induction in a
variety of bacteria including Pseudomonas aeruginosa [47,48]. For
many bacteria ppGpp is a more potent effector molecule than
pppGpp, suggesting a need for increased levels of Guanosine-59-
triphosphate,39-diphosphate pyrophosphatase [47,49].
Additional considerations and recommendations for
human microbiome studies
We used sputum samples as a proxy for the human respiratory
tract, much as fecal samples have been used as a proxy for the
human gut [18–20]. Expectorated sputum has been routinely
exploited as a rapid, inexpensive, non-invasive method to sample
the lung and lower respiratory tract, and sputum samples can
achieve sensitivity and accuracy comparable to bronchoalveolar
lavage for detection of respiratory infections [50]. T-RFLP analysis
of bacterial communities demonstrated that sputum is not
substantially contaminated by saliva and bacterial flora of the
oral cavity [34]. However, the degree to which sputum represents
the upper and lower respiratory tract is unknown, especially in
healthy individuals. Microbial communities in fecal samples have
been shown to differ significantly from those in intestinal mucosal
samples, based on 16S rDNA analysis, and similarly, sputum
samples may contain different communities than the lung or lower
respiratory tract [19].
In this study, human genomic DNA contamination was
detected bioinformatically and removed. Previously, we sequenced
control viromes from CF sputum which were not DNase I treated.
These metagenomes contained over 90% of sequences from
human genomic DNA as determined by BLASTn analysis (data
not shown). This human DNA comes from neutrophils present in
the airway, either through the active dissemination of neutrophil
extracellular traps (NETs) or by the release of cellular contents
during cell death [51]. Using the protocol described above, the
percent of human DNA detected ranged from 10% to 34%
(Table 2). This was markedly lower than in the control
metagenomes, and was comparable to the percentage of human
DNA (24% and 36%) obtained by Allander et al. [16] for viral
isolation from pooled nasal aspirate samples. As studies of the
human microbiome move away from characterization of microbes
using 16S rDNA and towards complete metagenomic analysis of
Figure 7. Distribution of similarities to metabolic subsystems in respiratory viromes. (A) Distribution of top-level subsystems in
respiratory tract viromes. (B) Second-level subsystems from the SEED hierarchy for aromatic metabolism. Non-CF viromes are shown in blue, CF
viromes 1–4 are shown in red, and CF5 is in gray. Subsystems determined by XIPE to be over-represented in a particular group are marked with a (+)
while those that are under-represented are marked with an asterisk (*).
doi:10.1371/journal.pone.0007370.g007
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contamination becomes unavoidable.
After all contaminating sequences were removed, there were still
at least 130,000 sequences comprising over 30 Mbp in all
metagenomes. To verify the presence of viruses in the metagen-
omes, we assembled two metagenomes and compared contigs to the
non-redudant database using BLASTn. There were 23 contigs
assembled from Non-CF2 which had BLASTn matches to
Streptococcus phage Cp-1 (E-value ,10
25), with an alignment length
greater than 50 bp, and greater than 85% identity (Figure S4). The
assembly of the CF3 metagenome yielded high coverage and
significant BLASTn hits to the genome of H. influenza prophage Mu
(Figure S5).
Here, we isolated DNA viruses from sputum, including both
phage and eukaryotic viruses. The majority of respiratory
infections (.75%) have been attributed to RNA viruses such as
rhinoviruses, coronaviruses, and paramyxoviruses, so many
previous studies have focused on the characterization of RNA
viruses in the respiratory tract [38]. CF is predominantly a
microbial disease, and phage are known to exert important top-
down controls on microbial communities [52]. However, little
work has been done to describe phage communities and DNA
viruses associated with CF or with the airways in general [4,38].
Over 98% of all completely sequenced phage have DNA genomes,
therefore to assess phage diversity, taxonomy, and function, it was
necessary to isolate viral DNA [53]. Future studies of the
respiratory tract virome should be expanded to include charac-
terization of RNA viral communities.
A caveat to this study was the use of Multiple Displacement
Amplification (MDA) with phi29 polymerase to amplify viral DNA
prior to pyrosequencing. MDA generally provides an even
representation of genomes except at the ends, however, certain
genomes (smalland circular or large and linear) may be preferentially
amplified [54,55]. To avoid random biases introduced by initial
reaction conditions, we performed five separate amplifications which
were then combined. All of the metagenomes used here were
collected, processed and amplified in an identical manner, so any
biases would have been introduced equally in all samples.
Conclusions
Metagenomic analysis of the human respiratory tract DNA
virome illustrated that airway viral communities in the diseased
and non-diseased states are defined by metabolism and not by
taxonomy. The non-diseased airway virome contains a set of
shared core metabolic functions, which deviate strongly in the face
of chronic disease. These deviations are driven by dramatic
environmental changes in the airways, induced by the nature of
cystic fibrosis, such as the introduction of hypoxic microenviron-
ments and novel carbon sources [26,27]. In cases where phage
taxonomy was shared between Non-CF and CF individuals,
metabolic functions still remained distinct. The converse was also
true, that is, even when Non-CF viromes differed in phage and
eukaryotic viral constituents, they maintained typical Non-CF
metabolic profiles. The presence of two alternative metabolic
states in CF reflects the heterogenous nature of disease. Though
CF is generally considered to be well-characterized, there is still
inherent individual variation. The need for alternative therapies
for CF is increasing, as microbial antibiotic resistance becomes
widespread. The results of this study suggest that CF therapeutics
might be better aimed at changing the environment of the airways
rather than targeting dominant taxa.
Methods
Ethics statement
Subject recruitment and sample collection were approved by
the San Diego State University Institutional Review Board (SDSU
IRB 2121) and Environmental Health Services (BUA 06-02-
062R). Written consent forms were obtained from all study
subjects.
Study population
The five individuals with CF who volunteered for this study
were patients at the Cystic Fibrosis Foundation accredited Adult
cystic fibrosis Clinic at the University of California San Diego
Medical Center. Patients were eligible if they could be classified as
clinically stable (i.e., in a non-exacerbated state and free from
systemic antibiotic therapy for at least thirty days), and had no
reportable cold or flu-like symptoms in the previous thirty days. All
volunteers with CF were screened for signs and symptoms of a
upper respiratory infection for the thirty days prior to the study.
All CF subjects were required to have a well documented diagnosis
with either two known mutations in the cystic fibrosis Transmem-
brane Regulator (CFTR) or an abnormally high sweat chloride

















NonCF1Asthma 286192 18% (52142) 82% (234050) 54465453 229 41.3 1.07
NonCF2 281687 34% (97091) 66% (184596) 41522972 215 40.1 1.01
NonCF3 240848 10% (23149) 90% (217699) 51487425 236 40.5 0.98
NonCF4Spouse 339107 32% (107911) 68% (231196) 53415637 232 40.6 0.89
NonCF5 345112 18% (62232) 82% (282880) 62464670 219 43.5 0.97
CF1 180647 19% (33451) 81% (147196) 33631380 226 41.5 1.04
CF2 225240 15% (33594) 85% (191646) 43741746 228 43.3 1.00
CF3 184410 25% (45891) 75% (138519) 34335377 246 42.8 0.87
CF4 266135 18% (28593) 82% (217270) 45559961 203 43.2 0.84
CF5 220356 18% (39909) 82% (180447) 41011286 226 43.0 1.09
All odds ratios were within normal range (0.78 to 1.23). All human sequences were removed prior to further bioinformatic analysis.
doi:10.1371/journal.pone.0007370.t002
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in their sputum, as determined by culturing in the clinic’s
microbiology lab. The five CF individuals randomly selected for
the study consisted of two males and three females. The age range
was from 20 to 35 years and all patients had severe airway
obstruction as assessed by standard spirometry (FEV1,50% of
predicted).
Four Non-CF volunteers were recruited from the campus of San
Diego State University, and were subject to the same exclusion
criteria for upper respiratory infection. One of these Non-CF
individuals had mild asthma controlled by medication. A final
Non-CF volunteer was the spouse of a CF patient and was
recruited from the greater San Diego area. The five Non-CF
individuals consisted of four females and one male, with an age
range of 24 to 50 years.
Sample collection
Sputum samples of approximately 10 ml were obtained from
CF patients at the Adult cystic fibrosis Clinic by expectoration into
a sterile cup, as directed by clinic staff. Since sputum expectoration
is difficult in general for Non-CF individuals, all Non-CF subjects
were first required to do an oral rinse with water to prevent
excessive salivary contamination and then take five deep breaths to
loosen lung secretions. Subjects were then instructed to cough
deeply into a sterile cup. The deep breathing and coughing
procedures were repeated until at least 1 ml of sputum was
obtained.
Metagenomic library preparation
All sputum samples were diluted with an equal volume of
Suspension Medium (SM) buffer (1 M NaCl, 10 mM MgSO4,
50 mM Tris-HCl pH 7.4). To aid in mucus dissolution, samples
were incubated with 10 ml of 6.5 mM dithiothreitol (Acros
Organics: Morris Plains, New Jersey) for 30 minutes at 37uC.
The treated sputum was homogenized using a PowerGen 125
mechanical homogenizer (Fisher Scientific: Hampton, New
Hampshire) until it was uniform in color and there was no visible
particulate debris. Homogenized samples were filtered through a
0.8 micron black polycarbonate filter (GE Water & Process
Technologies: Trevose, Pennsylvania) followed by a 0.45 micron
MILLEXHHV filter (Millipore: Carrigtwohill, Colorado) to
remove eukaryotic and microbial cells. Viruses in the 0.45 micron
filtrate were purified and concentrated using a cesium chloride
(CsCl) gradient to remove free DNA and any remaining cellular
material [56]. After collection of viral concentrates from the CsCl
gradient, the presence of virus-like particles (VLPs) and the
absence of microbial contamination were verified by epifluores-
cence microscopy using SYBRH Gold (Invitrogen: Eugene,
Oregon) as described in [56]. Sputum samples from healthy
subjects contained approximately 10
7 VLPs per ml, while the
samples from CF patients contained approximately 10
9 VLPs per
ml. A sample epifluoresence micrograph is shown in Figure S6.
Chloroform was added to the viral concentrates to rupture the
membranes of any remaining cells. Following a one hour
incubation and centrifugation, choloroform was removed by
pipetting. To degrade any remaining free DNA prior to viral
DNA extraction, samples were treated with 2 units per ml of Dnase
I (Sigma-Aldrich: St. Louis, MO) at 37uC for 1 hour. Viral DNA
was isolated using CTAB/phenol:choloroform extractions and
amplified using multiple displacement amplification with Phi29
polymerase [56]. Viral DNA was sequenced at 454 Life Sciences
(Branford, CT) using the GSFLX pyrosequencing platform to
produce ten total viral metagenomic libraries. The ten viral
metagenomes are accessible from NCBI (www.ncbi.nlm.gov)
under the genome project ID 39545.
Initial bioinformatic processing of metagenomes
All metagenomes were compared to the Human Genome build
36.3 (http://www.ncbi.nlm.mih.gov) using BLASTn to determine
how effective the combination of cesium chloride density gradient
centrifugation and DNase I treatment was for removing human
genomic contamination from the viral preps [39]. Sequences with
80% identity over 80% of their length to human sequences were
considered contaminating human genomic DNA and were
removed prior to further bioinformatic analyses. Characteristics
of viromes and the percentage of human genomic sequences
detected are provided in Table 2.
Following removal of human sequences, dinucleotide relative
abundance analysis was used as a secondary screen to detect
human DNA contamination, which manifests as an overall
depression of CG dinucleotides [57,58]. In all of the decontam-
inated metagenomes, the relative abundance odds ratios for CG
dinucleotides were between 0.83 and 1.09, within the normal
range as defined by Karlin, indicating successful removal of
human DNA (Table 2) [57,58]. All viromes were AT rich (in
comparison to microbial metagenomes) as expected, with GC
content between 40–43%, just below the average of approximately
45% previously reported for viral metagenomes [58]. The human
genomic DNA decontaminated metagenomic libraries were
named according to the subject group they were derived from
(Non-CF or CF) and were numbered 1 through 5 in each group.
Viromes derived from the individual with asthma and the CF
spouse were designated as Non-CF1Asthma and Non-CF4Spouse.
Diversity estimation
To estimate viral diversity and community structure within
metagenomes, contig spectra were generated using the free
software Circonspect (http://sourceforge.net/projects/circonspect/).
Average contig spectra were calculated using assemblies of 10,000
randomly selected sequences with enough repetitions to achieve 26
coverage of each metagenome. The assembly parameters were 98%
minimal match and 35 base pair overlap. Sequences less than 100 base
pairs were discarded and all other sequences were trimmed to 100 base
pairs prior to assembly to obtain identical sequence size in the repeated
assemblies. Average contig spectra were used as inputs to Phage
Communities from Contig Spectra (PHACCS) tool (http:biome.sdsu.
edu/phaccs), which estimates diversity using rank-abun [36]. Diversity
estimates were based on the best-fit model, in this case the logarithmic
model.
Sequential BLAST analysis
Metagenomic libraries were compared to each other using
BLASTn to find shared sequences between all Non-CF viromes
and all CF viromes. One metagenome from each set (Non-CF or
CF) was chosen randomly and compared to a second randomly
selected metagenome. Common sequences (E-value,10
25 and a
minimum of 98% similarity over at least 35 base pairs) were
identified and then used as a database for BLASTn versus a third
metagenome. This was repeated for the fourth and fifth
metagenomes. The entire process was repeated using a different
random ordering of metagenomes. Sequential BLASTn analysis
resulted in two datasets, one containing sequences common to all
Non-CF metagenomes and the other with sequences common to
CF metagenomes. The common Non-CF sequences were then
compared using BLASTn to all CF metagenomes to determine
which sequences were not present in any CF library (i.e., unique to
Respiratory Viromes
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unique CF sequences.
Comparison to phage and viral genome databases
Metagenomic libraries were compared to two boutique
databases, the first containing 510 complete phage genomes
(http://phage.sdsu.edu/phage) and the second, 3,074 complete
eukaryotic viral genomes (http://www.ncbi.nlm.nih.gov/genomes/
VIRUSES/viruses.html) using tBLASTx with an E-value cutoff of
10
25 [39]. Counts of best tBLASTx similarities to each genome
were normalized for genome size by weighting the number of
significant similarities by the total number of base pairs in the
database divided by the size of the genome in base pairs. Similarity
counts were also normalized for the number of sequences per
metagenome, to allow direct comparisons between metagenomes.
Normalized best tBLASTx similarities to the phage database were
plotted against the Phage Proteomic Tree version 4 (http://phage.
sdsu.edu/,rob/PhageTree/v4) using Bio-Metamapper [53,56].
Similarities to dsDNA, ssDNA, and retro-transcribing eukaryotic
viruses were plotted according to NCBI taxonomy (http://www.
ncbi.nlm.nih.gov/genome). Similarities to RNA viruses were not
included because they were artifactual, since only DNA was
sequenced in this study. Significant similarities to RNA viruses
comprised less than 1% of all tBLASTx similarities.
Assessment of metabolic potential
The metabolic potential of each virome was assessed by
BLASTx (E-value,10
25) comparison to the SEED database
using the MG-RAST service [59,60]. MG-RAST assigns sequenc-
es to three hierarchical levels of metabolic subsystems, which
consist of groups of genes that comprise a metabolic function or
pathway [61]. The non-parametric statisical program XIPE was
used to detect significant differences between metabolic profiles of
viral metagenomes at a 95% confidence level [62]. XIPE identifies
the specific subsystems driving the differences between metagen-
omes, and in which metagenome the function was are over-
represented.
Complete metagenomic assembly
Complete assembly of the Non-CF2 and CF3 metagenomes was
performed using PHRAP as a quality check to confirm sucessful
isolation of viral genomes [63]. These two metagenomes were
assembled because they had high coverage of phage genomes as
indicated by tBLASTx. There were 9,508 contigs ranging in size
from 40 to 14,982 bp for Non-CF2, and 8,163 contigs from 212 to
7,748 base pairs for CF3. Contigs were compared to the non-
redundant nucleotide database maintained at NCBI (http://www.
ncbi.nlm.nih.gov) using BLASTn to assign taxonomy.
Statistical analyses
All statistical analyses, with the exception of XIPE, were
performed using the software package R (www.r-project.org) [64].
Principal components analysis (PCA) with the R function prcomp
was used to examine overall taxonomic similarities between
metagenomes [65]. The first two principal components were used
to generate 2D scatter plots. Non-metric multidimensional scaling
(NM-MDS) with the R function isoMDS was used to determine
relationships between metagenomes based on metabolic profiles.
The analysis was performed with NM-MDS instead of PCA for
metabolic potential because all metagenomes had at least one hit
to each of the 25 subsystems (i.e., there were no zero values).
Similar to PCA, NM-MDS does not require a priori classification of
the data and plotting the MDS coordinates shows natural
grouping patterns. Clusters observed in PCA and NM-MDS
scatterplots were confirmed statistically using k-means clustering.
To determine the optimal number of clusters, within-group sums
of squares were calculated for partitions involving between 1 and 9
clusters [63,65]. Cluster membership was determined by using the
R function kmeans with the optimal number of clusters.
Supporting Information
Table S1 Taxonomic designations of metagenomic sequences
based on BLASTn (e-value,1025) comparison to the non-
redundant database at NCBI. Sequences which had no significant
similarities were assigned as ‘‘unknown’’, while those with
significant similarities were considered to be ‘‘known’’. There
were no sequences with significant similarities to Archaea, and
therefore known sequences were classified as either viral (including
phage and eukaryotic viruses), bacterial, or eukaryotic.
Found at: doi:10.1371/journal.pone.0007370.s001 (0.02 MB
DOC)
Table S2 Results of comparison of metagenomes to the database
of 510 fully sequenced phage genomes using tBLASTx (e-
value,1025). The number of unique genomes refers to how
many phage genomes had a significant BLAST similarity in only
one of the five Non-CF or CF metagenomes.
Found at: doi:10.1371/journal.pone.0007370.s002 (0.02 MB
DOC)
Table S3 Relative abundances of the 19 phage genomes which
appear in all human respiratory tract viromes based on tBLASTx
similarities (e-value,1025). Relative abundances were calculated
as the normalized number of similarities to each phage divided by
the total number of similarities to phage for each metagenome.
Found at: doi:10.1371/journal.pone.0007370.s003 (0.02 MB
DOC)
Table S4 Results of comparison of metagenomes to the database
of 3074 fully sequenced eukaryotic viral genomes using tBLASTx
(e-value,1025). The number of unique genomes refers to how
many viral genomes had a significant BLAST similarity in only
one of the five Non-CF or CF metagenomes.
Found at: doi:10.1371/journal.pone.0007370.s004 (0.02 MB
DOC)
Table S5 Relative abundances of the 20 eukaryotic DNA viral
genomes which appear in all human respiratory tract viromes
based on tBLASTx similarities (e-value,1025). Relative abun-
dances were calculated as the normalized number of similarities to
each virus divided by the total number of similarities to eukaryotic
DNA viruses for each metagenome.
Found at: doi:10.1371/journal.pone.0007370.s005 (0.02 MB
DOC)
Figure S1 Figure S1. Combined coverage of Retiucloendothe-
liosis virus across all CF metagenomes as determined by tBLASTx.
The graphic of the 8295 kb Reticuloendotheliosis genome is from
NCBI (http://www.ncbi.nlm.nih.gov).
Found at: doi:10.1371/journal.pone.0007370.s006 (0.03 MB
PNG)
Figure S2 Supplementary Figure 2. Combined coverage of Suid
herpesvirus 1 and Cercopithecine herpesvirus 2 across all Non-CF
and CF metagenomes as determined by tBLASTx. The graphics
of the two reference genomes are from NCBI (http://www.ncbi.
nlm.nih.gov).
Found at: doi:10.1371/journal.pone.0007370.s007 (0.11 MB
PNG)
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sequences with known and unknown metabolic functions as
determined by BLASTx to the SEED database. A sequence was
considered as known if it had a significant (e-value,1025) hit to a
gene in a metabolic pathway.
Found at: doi:10.1371/journal.pone.0007370.s008 (0.02 MB
PNG)
Figure S4 Supplementary Figure 4. Coverage of the Strepto-
coccus pneumonia phage Cp-1 genome in metagenome Non-CF2
by raw metagenomic sequences as determined by tBLASTx (A)
and by assembled contigs as determined by BLASTn (B). The
graphic of the 19,343 kb phage Cp-1 genome is from NCBI
(http://www.ncbi.nlm.nih.gov).
Found at: doi:10.1371/journal.pone.0007370.s009 (0.11 MB
PDF)
Figure S5 Coverage of the Haemophilus influenza prophage
Mu genome in the CF6 metagnome by raw metagenomic
sequences as determined by TBLASTX (A) and by assembled
contigs as determined by BLASTn (B). The graphic of the
43033 kb prophage Mu genome is from NCBI (http://www.ncbi.
nlm.nih.gov).
Found at: doi:10.1371/journal.pone.0007370.s010 (0.21 MB
PDF)
Figure S6 Virus-like Particles (VLPs) from the sputum sample of
a CF patient. The VLPs were visualized by capture on a 0.02 mm
Anodisc filter, SYBR Gold staining, and viewing under an
epifluorescence microscope. The viruses appear as tiny bright
pinpricks of light.
Found at: doi:10.1371/journal.pone.0007370.s011 (0.26 MB
PDF)
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